Cambridge Oncology Ltd
11658105
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2025
micro entity
Next accounts due
30/09/2027
Confirmation statement
Last: 04/11/2025
Due 18/11/2026
Industry
Officers
director · Since 05/11/2018
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 52
Also on 5 other boards
director · Since 06/12/2022
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 78
Also on 1 other board
Persons with Significant Control
Former PSCs
Professor Melinda Jane Duer
Ceased 11/03/2024
CompanyRankvs 328+ SIC 72110 peers77
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£1.7M
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£1.7M
Working capital
Current Assets
£1.7M
Current Liabilities
£1k
Fixed Assets
£802
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1544.89 | +£0 |
| 2025 | 1544.89 | -£216k |
| 2024 | 192.25 | -£303k |
| 2023 | 119.10 | -£309k |
| 2022 | 44.51 | +£2.6M |
| 2021 | 5.94 | -£200k |
| 2020 | 26.50 | -£39k |
| 2019 | 1.85 | — |
Derived from filed accounts. Not audited figures.